Latest News and Press Releases

TORONTO, July 23, 2024 (GLOBE NEWSWIRE) -- The Canadian International Air Show (CIAS) returns Labour Day weekend to celebrate 75 historic years of soaring over Toronto and the 100th Anniversary of...

TORONTO, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The Canadian International Air Show (CIAS) officially announces their 75th Anniversary performance headliners. The 2024 initial lineup includes the...

CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced that the Board of Directors of the Company acting solely by all of its independent and...

Positive topline results for CY6463 announced in two clinical studies in patients with Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS) and Cognitive Impairment...

Study data demonstrate positive effects of CY6463 on cognition and inflammation after two weeks of dosing in patients with stable schizophrenia on standard of care Oral, once-daily CY6463 was well...

Characterizing the novel neuropharmacology of CY6463’s NO-sGC-cGMP signal modulation in an integrated clinical strategy currently involving three ongoing, exploratory, biomarker-rich, signal seeking...

Phase 2a study in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) enrollment closed; topline data expected in Q2 2022      Phase 1b study in Cognitive Impairment...

CAMBRIDGE, Mass. and PARIS, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Ariana Pharma today announced an artificial intelligence-driven, precision medicine...

Le QX Inspiration laisse entrevoir le futur design de la gamme électrique haute performance d’INFINITI.Il est l’œuvre du Canadien Karim Habib, directeur général du design, INFINITI Motor Company, Ltd....

The INFINITI QX Inspiration signals the future of INFINITI design and vision for high-performance electrified vehiclesConcept led by Canadian Karim Habib, Executive Design Director, INFINITI Motor...